ArticleAntiviral research2021

Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion protein.

Hristo L Svilenov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.